Population pharmacokinetics of mycophenolic acid in lung transplant recipients with and without cystic fibrosis.

Eur J Clin Pharmacol

Department of Clinical, Social and Administrative Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI, 48109, USA.

Published: June 2015

AI Article Synopsis

  • The study aimed to investigate and compare how mycophenolic acid (MPA) is processed in the bodies of lung transplant patients with cystic fibrosis (CF) versus those without it (NCF) after taking the drug mycophenolate mofetil (MMF).
  • Researchers conducted three pharmacokinetic (PK) visits over time, using nonlinear mixed effects modeling to understand how different factors influence MPA metabolism and clearance.
  • Results showed that CF patients absorb MPA more slowly and have higher clearance rates and distribution volumes than NCF patients, indicating the need for careful monitoring of MPA levels in CF patients to optimize treatment.

Article Abstract

Purpose: The objective of this work was to characterize and compare the population pharmacokinetics (PK) mycophenolic acid (MPA) in adult lung transplant recipients with cystic fibrosis (CF) and without the disease (NCF) following repeated oral administration of the prodrug mycophenolate mofetil (MMF) as an immunosuppressant.

Methods: Three separate 12-h PK visits were conducted for lung transplant patients with or without CF following repeated MPA treatment with at least a 2-week break between the visits. A population PK model was developed using nonlinear mixed effects modeling (NONMEM), and the contribution of physiological and pathological factors and time dependence of apparent oral clearance (CL/F) were assessed.

Results: For both CF and NCF patients, MPA serum concentration-time profiles were best described by a two-compartment PK model with first-order absorption. CF patients had a slower absorption rate (Ka), and elevated CL/F and volume of distribution (Vd/F) compared with NCF patients. There is a significant contribution of body weight and CF disease to MPA CL/F, and both were included in the final model as covariates.

Conclusions: The population PK model developed from our study successfully characterizes the absorption, distribution, and elimination of MPA in lung transplant recipients with or without CF disease. The decrease of MPA absorption and increase of both oral clearance (CL/F) and volume of distribution (V2/F and V3/F) in the CF patients would suggest the importance of MPA therapeutic monitoring for this group.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-015-1854-7DOI Listing

Publication Analysis

Top Keywords

lung transplant
16
transplant recipients
12
population pharmacokinetics
8
pharmacokinetics mycophenolic
8
mycophenolic acid
8
recipients cystic
8
cystic fibrosis
8
population model
8
model developed
8
oral clearance
8

Similar Publications

Impact of pulmonary rehabilitation on survival in people with Interstitial lung disease.

Chest

January 2025

Respiratory Research@Alfred, Central Clinical School, Monash University, VIC, Australia; Institute for Breathing and Sleep, VIC, Australia; Department of Physiotherapy, Alfred Health, VIC, Australia.

Background: Pulmonary rehabilitation (PR) is a beneficial intervention for people with interstitial lung disease (ILD), however the effect of PR on survival is unclear. This study compared the survival outcomes in people with ILD who were allocated to PR versus those who were allocated to control in two published randomised controlled trials (RCTs).

Research Question: Does participation in PR impact survival among people with ILD?

Study Design And Methods: The combined data from the two previous RCTs of PR in ILD were included.

View Article and Find Full Text PDF

Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort study.

Lancet Respir Med

January 2025

Division of Respiratory Medicine and Gastroenterology, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK. Electronic address:

Background: Bronchiectasis is a disease with a global impact, but most published data come from high-income countries. We aimed to describe the clinical characteristics of patients with bronchiectasis in China.

Methods: The Chinese Bronchiectasis Registry (BE-China) is a prospective, observational cohort enrolling patients from 111 hospitals in China.

View Article and Find Full Text PDF

Objective: The effects of sex hormones remain largely unexplored in pheochromocytomas and paragangliomas (PPGLs) and gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Methods: We evaluated the effects of estradiol, progesterone, Dehydroepiandrosterone sulfate (DHEAS), and testosterone on human patient-derived PPGL/GEP-NET primary culture cell viability (n = 38/n = 12), performed next-generation sequencing and immunohistochemical hormone receptor analysis in patient-derived PPGL tumor tissues (n = 36).

Results: In PPGLs, estradiol and progesterone (1 µm) demonstrated overall significant antitumor effects with the strongest efficacy in PPGLs with NF1 (cluster 2) pathogenic variants.

View Article and Find Full Text PDF

Association of Grit and Resilience With Short-Term Post-Transplant Outcomes in Lung Allograft Recipients.

Clin Transplant

January 2025

Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USA.

The importance of mental toughness on lung transplant outcomes is unknown. We performed a pilot study to assess whether pretransplant grit and resilience are associated with short-term posttransplant outcomes. We enrolled 31 lung transplant candidates, of whom 7 (26%) had greater mental toughness, defined as the upper tertile for both grit and resilience within our cohort.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!